| Immunomodulatory Oligonucleotide studied in …STUDIED_INderived37 of 37show fewer |
|---|
| → studied in | NCT07844187Phase 1/Phase 2 · not yet recruiting TQB2922 Injection Given Under the Skin With Chemotherapy as Initial Treatment for Colorectal Cancer That Has Spread · 37 trials list this drug (18 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07069712Phase 2 · recruiting A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma · 37 trials list this drug (18 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07015242Phase 2 · recruiting A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma · 37 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05253846Phase 2 · active not recruiting Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 · 37 trials list this drug (18 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07441369Phase 2 · enrolling by invitation Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer · 37 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07056777Phase 1/Phase 2 · recruiting Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer · 37 trials list this drug (18 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621497Phase 2 · not yet recruiting FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II) · 37 trials list this drug (18 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06094140Phase 2 · active not recruiting NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer · 37 trials list this drug (18 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07412613Phase 3 · recruiting Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer · 37 trials list this drug (18 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07543744Phase 1 · recruiting A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI · 37 trials list this drug (18 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06544655Phase 1 · active not recruiting A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors · 37 trials list this drug (18 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04245865Phase 2 · active not recruiting Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer · 37 trials list this drug (18 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05846867Phase 1/Phase 2 · active not recruiting A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer · 37 trials list this drug (18 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06703177Phase 1/Phase 2 · recruiting A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors · 37 trials list this drug (18 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06313801Phase 2 · recruiting Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions · 37 trials list this drug (18 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04141995Phase 2 · terminated FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer · 37 trials list this drug (18 active) | — | — | Pancreatic Carcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06648525Phase 2 · not yet recruiting Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC · 37 trials list this drug (18 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06493760Phase 2 · recruiting A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients · 37 trials list this drug (18 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02705300Phase 2 · completed Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer · 37 trials list this drug (18 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475326Phase 2 · unknown Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer · 37 trials list this drug (18 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06531278Phase 2 · recruiting Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety · 37 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05480280Phase 2 · unknown mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer · 37 trials list this drug (18 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05640726Phase 2 · unknown The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy · 37 trials list this drug (18 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02644967Phase 2 · completed A Phase 2 Study to Assess the Safety and Efficacy of IMO-2125 With 8 mg Ipilimumab in Patients With Metastatic Melanoma · 37 trials list this drug (18 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01987102Phase 1/Phase 2 · completed Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX. · 37 trials list this drug (18 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03052205Phase 1 · completed A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors · 37 trials list this drug (18 active) | — | — | Solid Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02620800Phase 1 · completed Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer · 37 trials list this drug (18 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02092909Phase 1/Phase 2 · terminated Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia · 37 trials list this drug (18 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03668418unknown Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos · 37 trials list this drug (18 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00729053Phase 2 · completed Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma · 37 trials list this drug (18 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02252146Phase 1/Phase 2 · completed Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation · 37 trials list this drug (18 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00660894Phase 3 · completed Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery · 37 trials list this drug (18 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02785146Phase 3 · unknown Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer · 37 trials list this drug (18 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00633529Phase 1 · completed Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC · 37 trials list this drug (18 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719199Phase 1 · terminated Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer · 37 trials list this drug (18 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00385970Phase 3 · unknown A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer · 37 trials list this drug (18 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01679327Phase 2 · unknown Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer · 37 trials list this drug (18 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |